Literature DB >> 30256393

Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes.

Joseph Y Cheung1,2, Jennifer Gordon3,4, JuFang Wang1, Jianliang Song1, Xue-Qian Zhang1, Fabian Jana Prado1, Santhanam Shanmughapriya1,5, Sudarsan Rajan1,5, Dhanendra Tomar1,5, Farzaneh G Tahrir3,4, Manish K Gupta3,4, Tijana Knezevic3,4, Nana Merabova3,4, Christopher D Kontos6, Joseph M McClung7, Paul E Klotman8, Muniswamy Madesh1,5, Kamel Khalili3,4, Arthur M Feldman2.   

Abstract

The pathophysiology of human immunodeficiency virus (HIV)-associated cardiomyopathy remains uncertain. We used HIV-1 transgenic (Tg26) mice to explore mechanisms by which HIV-related proteins impacted on myocyte function. Compared to adult ventricular myocytes isolated from nontransgenic (wild type [WT]) littermates, Tg26 myocytes had similar mitochondrial membrane potential (ΔΨ m ) under normoxic conditions but lower Δ Ψ m after hypoxia/reoxygenation (H/R). In addition, Δ Ψ m in Tg26 myocytes failed to recover after Ca 2+ challenge. Functionally, mitochondrial Ca 2+ uptake was severely impaired in Tg26 myocytes. Basal and maximal oxygen consumption rates (OCR) were lower in normoxic Tg26 myocytes, and further reduced after H/R. Complex I subunit and ATP levels were lower in Tg26 hearts. Post-H/R, mitochondrial superoxide (O 2 •- ) levels were higher in Tg26 compared to WT myocytes. Overexpression of B-cell lymphoma 2-associated athanogene 3 (BAG3) reduced O 2 •- levels in hypoxic WT and Tg26 myocytes back to normal. Under normoxic conditions, single myocyte contraction dynamics were similar between WT and Tg26 myocytes. Post-H/R and in the presence of isoproterenol, myocyte contraction amplitudes were lower in Tg26 myocytes. BAG3 overexpression restored Tg26 myocyte contraction amplitudes to those measured in WT myocytes post-H/R. Coimmunoprecipitation experiments demonstrated physical association of BAG3 and the HIV protein Tat. We conclude: (a) Under basal conditions, mitochondrial Ca 2+ uptake, OCR, and ATP levels were lower in Tg26 myocytes; (b) post-H/R, Δ Ψ m was lower, mitochondrial O 2 •- levels were higher, and contraction amplitudes were reduced in Tg26 myocytes; and (c) BAG3 overexpression decreased O 2 •- levels and restored contraction amplitudes to normal in Tg26 myocytes post-H/R in the presence of isoproterenol.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV cardiomyopathy; adenovirus; adult myocyte culture; mitochondria bioenergetics; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 30256393      PMCID: PMC6318060          DOI: 10.1002/jcp.27232

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  45 in total

1.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Authors:  A Mocroft; B Ledergerber; C Katlama; O Kirk; P Reiss; A d'Arminio Monforte; B Knysz; M Dietrich; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

2.  HIV-1 induces cardiomyopathyby cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling.

Authors:  Milan Fiala; Waldemar Popik; Jian-Hua Qiao; Albert S Lossinsky; Timothy Alce; Kenix Tran; Wendy Yang; Kenneth P Roos; James Arthos
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

3.  Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange.

Authors:  Amy L Tucker; Jianliang Song; Xue-Qian Zhang; Jufang Wang; Belinda A Ahlers; Lois L Carl; J Paul Mounsey; J Randall Moorman; Lawrence I Rothblum; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-02       Impact factor: 4.733

4.  Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine.

Authors:  W Lewis; I L Grupp; G Grupp; B Hoit; R Morris; A M Samarel; L Bruggeman; P Klotman
Journal:  Lab Invest       Date:  2000-02       Impact factor: 5.662

5.  Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology.

Authors:  Y Y Zhou; S Q Wang; W Z Zhu; A Chruscinski; B K Kobilka; B Ziman; S Wang; E G Lakatta; H Cheng; R P Xiao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

6.  Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage.

Authors:  Scott M Raidel; Chad Haase; Natalie R Jansen; Rodney B Russ; Roy L Sutliff; Leonard W Velsor; Brian J Day; Brian D Hoit; Allen M Samarel; William Lewis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-05       Impact factor: 4.733

7.  Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).

Authors:  G Barbaro; G Di Lorenzo; M Soldini; G Giancaspro; B Grisorio; A Pellicelli; G Barbarini
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

8.  Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.

Authors:  J B Kopp; M E Klotman; S H Adler; L A Bruggeman; P Dickie; N J Marinos; M Eckhaus; J L Bryant; A L Notkins; P E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 9.  Immunopathogenesis of HIV-related heart muscle disease: current perspectives.

Authors:  Peter F Currie; Nicholas A Boon
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

Review 10.  Use of the transgenic mouse in models of AIDS cardiomyopathy.

Authors:  William Lewis
Journal:  AIDS       Date:  2003-04       Impact factor: 4.177

View more
  6 in total

1.  Sex-specific neurogenic deficits and neurocognitive disorders in middle-aged HIV-1 Tg26 transgenic mice.

Authors:  Raj Putatunda; Yonggang Zhang; Fang Li; Philip Regis Fagan; Huaqing Zhao; Servio H Ramirez; Domenico Praticò; Mary F Barbe; Wenhui Hu
Journal:  Brain Behav Immun       Date:  2019-04-16       Impact factor: 7.217

2.  Human Immunodeficiency Virus Infection and Variation in Heart Failure Risk by Age, Sex, and Ethnicity: The HIV HEART Study.

Authors:  Alan S Go; Kristi Reynolds; Harshith R Avula; William J Towner; Rulin C Hechter; Michael A Horberg; Suma Vupputuri; Thomas K Leong; Wendy A Leyden; Teresa N Harrison; Keane K Lee; Sue Hee Sung; Michael J Silverberg
Journal:  Mayo Clin Proc       Date:  2021-12-13       Impact factor: 11.104

Review 3.  Advances in the role and mechanism of BAG3 in dilated cardiomyopathy.

Authors:  Leiling Liu; Kaijun Sun; Xiaojun Zhang; Ying Tang; Danyan Xu
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

4.  SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics.

Authors:  Karthik Ramachandran; Soumya Maity; Alagar R Muthukumar; Soundarya Kandala; Dhanendra Tomar; Tarek Mohamed Abd El-Aziz; Cristel Allen; Yuyang Sun; Manigandan Venkatesan; Travis R Madaris; Kevin Chiem; Rachel Truitt; Neelanjan Vishnu; Gregory Aune; Allen Anderson; Luis Martinez; Wenli Yang; James D Stockand; Brij B Singh; Subramanya Srikantan; W Brian Reeves; Muniswamy Madesh
Journal:  iScience       Date:  2022-01-01

5.  A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection.

Authors:  Prasanta K Dash; Fadhel A Alomar; Jesse L Cox; JoEllyn McMillan; Bryan T Hackfort; Edward Makarov; Brenda Morsey; Howard S Fox; Howard E Gendelman; Santhi Gorantla; Keshore R Bidasee
Journal:  Front Cardiovasc Med       Date:  2021-12-14

6.  Human immunodeficiency virus infection and risks of morbidity and death in adults with incident heart failure.

Authors:  Harshith R Avula; Andrew P Ambrosy; Michael J Silverberg; Kristi Reynolds; William J Towner; Rulin C Hechter; Michael Horberg; Suma Vupputuri; Thomas K Leong; Wendy A Leyden; Teresa N Harrison; Keane K Lee; Sue Hee Sung; Alan S Go
Journal:  Eur Heart J Open       Date:  2021-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.